Back | Next |
home / stock / srra / srra message board
Subject | By | Source | When |
---|---|---|---|
I think the report actually says no less | BuynowCryLater | investorshub | 12/23/2019 4:50:31 PM |
The Huge (1:100) R/S will kick in as | Value_Investor | investorshub | 12/19/2019 9:43:47 PM |
* * $SRRA Video Chart 12-09-2019 * * | ClayTrader | investorshub | 12/09/2019 10:13:51 PM |
Got 0,47,s | europtiger | investorshub | 12/09/2019 2:43:59 PM |
Pre-Market: $ 0.84 + 0.355 (73,19%) | dirkv | investorshub | 12/09/2019 2:04:44 PM |
Then it was still in the 0,20s | europtiger | investorshub | 12/09/2019 10:50:58 AM |
072 pm | europtiger | investorshub | 12/09/2019 9:54:39 AM |
0,72 pm!!! | europtiger | investorshub | 12/09/2019 9:54:08 AM |
Beauty at 0,70 pm lol | europtiger | investorshub | 12/09/2019 9:53:56 AM |
News: $SRRA Sierra Oncology Reports Decreased Transfusion Requirements | whytestocks | investorshub | 12/07/2019 5:00:15 PM |
znewcar1: SRRA 26% v8,6M c.485 f74M HpreM@.55 gap from .38 to .48 then sank to .434 where it got sup | znewcar1 | investorshangout | 12/06/2019 9:54:48 PM |
* * $SRRA Video Chart 12-06-2019 * * | ClayTrader | investorshub | 12/06/2019 9:11:49 PM |
Added .45 today.. | Liquid1974 | investorshub | 12/06/2019 1:24:46 PM |
Ditto this post - I was up to | RNsidersbuying | investorshub | 12/03/2019 2:41:52 PM |
Monster Move Underway... $SRRA | Golden Cross | investorshub | 12/03/2019 11:18:46 AM |
znewcar1: SRRA 44% v17,0M c.50 f74M H .535 S climbed off VWAP.43-.46 | znewcar1 | investorshangout | 12/03/2019 3:44:28 AM |
I sold 95% of my shares (1M+) at | Value_Investor | investorshub | 12/03/2019 3:33:33 AM |
Todays volume tells the story. Way above the average. | Ebondo | investorshub | 12/02/2019 11:50:08 PM |
* * $SRRA Video Chart 12-02-2019 * * | ClayTrader | investorshub | 12/02/2019 10:53:29 PM |
Im not even mad ... from being -65% | BuynowCryLater | investorshub | 12/02/2019 8:52:07 PM |
News, Short Squeeze, Breakout and More Instantly...
Dr. Stephen Dilly, Board member and biotechnology veteran, named the next President and CEO John Nicols to retire after ten years leading the transformation and growth of Codexis REDWOOD CITY, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading en...
– Submission seeks approval of momelotinib for the treatment of myelofibrosis – Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company on a mission to deliver transformative therapies for rare cancers, today announced the company has submi...